Bharat Biotech commenced clinical trial of MTBVAC vaccine in India
MTBVAC is the only vaccine for tuberculosis in clinical trials based on a genetically modified form of pathogen isolated from humans Mycobacterium TB which is unlike the BCG vaccine.
Bharat Biotech International Ltd said it started clinical trials of the Tuberculosis vaccine MTBVAC on adults in India. This is the first vaccine against Tuberculosis derived from a human source by the Spanish bio-pharmaceutical company, Biofabri.
The trials are initiated by Bharat Biotech in close collaboration with Biofabri, as per information. After completing a dose escalation trial in HIV uninfected adults, a Phase 2 study in HIV-infected adults started in 2024 to determine whether MTBVAC is safe in this population. The companies are optimistic that the new vaccine will be a milestone in global vaccinology and call it an example of public-private, national, and international collaboration.
Read Also : IndusInd Bank Q1 FY25 results, net profit at 2% YoYBharat Biotech will be conducting a Phase 3 trial as Biofabri has completed the Phase 1 and 2 trials in other countries. MTBVAC is the only vaccine for tuberculosis in clinical trials based on a genetically modified form of pathogen isolated from humans Mycobacterium TB which is unlike the BCG vaccine.
On the auspicious day of World Tuberculosis Day, March 24, Bharat Biotech has announced the evaluation of the trials for the safety and immunogenicity of MTBVAC in India, and similarly, a pivotal safety trial is planned in 2025.
Read Also : RBI issues guidelines on higher liquidity coverage ratio for retail deposits
News Must Read
- Karnataka Bank Announced record Q1 Net Profit at Rs. 400.33 CR
- NTPC, BHEL shares soar higher amid JV announcement in Budget 2024
- BEL signs tripartite MoU for manufacture of indigenised ammunition
- Goa Shipyard Limited launched first indigenous P1135.6 Frigate
- Chandan Sinha appointed as Non-Executive Part Time Chairman of RBL Bank
- OIL and Dolphin Drilling signs contract for hiring of Blackford Dolphin
- Cmde D.K. Murali, IN (Retd.) Joins as CMD of BECIL
- Samir Chandra Saxena Appointed as Director (Market Operation) of GRID-INDIA
- MOIL CMD bags Title 'CEO of the Year'
- ONGC sign MoU with GSI to advance geothermal exploration in Ladakh